Main Line Center for Laser Surgery
🇺🇸United States
Clinical Trials
5
Active:1
Completed:4
Trial Phases
2 Phases
Phase 4:3
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 4
3 (60.0%)Not Applicable
2 (40.0%)Effects of P-TIOX and Tixel Combined on Reducing Eye Wrinkles
Not Applicable
Active, not recruiting
- Conditions
- Periocular Fine Wrinkles
- First Posted Date
- 2025-10-29
- Last Posted Date
- 2025-10-29
- Lead Sponsor
- Main Line Center for Laser Surgery
- Target Recruit Count
- 20
- Registration Number
- NCT07222176
- Locations
- 🇺🇸
Main Line Center for Laser Surgery, Ardmore, Pennsylvania, United States
DaxibotulinimtoxinA for Treatment of Platysmal Neck Bands
Phase 4
Completed
- Conditions
- Aging
- Interventions
- First Posted Date
- 2024-01-26
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Main Line Center for Laser Surgery
- Target Recruit Count
- 20
- Registration Number
- NCT06225492
- Locations
- 🇺🇸
Main Line Center for Laser Surgery, Ardmore, Pennsylvania, United States
Hyaluronic Filler for Improvement of Radial Cheek Lines
Not Applicable
Completed
- Conditions
- Aging
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2025-10-29
- Lead Sponsor
- Main Line Center for Laser Surgery
- Target Recruit Count
- 20
- Registration Number
- NCT06074302
- Locations
- 🇺🇸
Main Line Center for Laser Surgery, Ardmore, Pennsylvania, United States
TCA 15% Chemical Peel for Improvement in Hand Lentigines
Phase 4
Completed
- Conditions
- LentigoPhotoaging
- Interventions
- Drug: 15% Trichloroacetic acid + 3% glycolic acid
- First Posted Date
- 2022-07-25
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Main Line Center for Laser Surgery
- Target Recruit Count
- 20
- Registration Number
- NCT05471947
- Locations
- 🇺🇸
Main Line Center for Laser Surgery, Ardmore, Pennsylvania, United States
Xeomin, Radiesse, and Belotero Facial/Neck Rejuvenational
Phase 4
Completed
- Conditions
- Photoaging
- Interventions
- Drug: Radiesse, Xeomin, Belotero
- First Posted Date
- 2021-09-10
- Last Posted Date
- 2022-07-07
- Lead Sponsor
- Main Line Center for Laser Surgery
- Target Recruit Count
- 22
- Registration Number
- NCT05039723
- Locations
- 🇺🇸
Main Line Center for Laser Surgery, Ardmore, Pennsylvania, United States
News
No news found